DermaFlow Alpha Multi-modal Quantitative Imaging of the Skin for Screening and Diagnosis in Primary Care

What this Trial Is About

Researchers are investigating the use of a full-body multi-modal imaging technology to help with screening, monitoring, and diagnosing various skin and circulatory conditions in primary care. This study focuses on assessing the accuracy of body measurements and the technology's ability to detect skin cancer, peripheral arterial disease, Raynaud's phenomenon, and other dermatological conditions. The imaging system combines high-resolution 2D and 3D color photos with thermal images to capture detailed information about skin lesions and microcirculation. The imaging technology uses camera systems that include 2D color cameras for capturing lesion appearance, 3D cameras for geometric alignment and measurements, and thermal cameras for detecting temperature changes linked to skin and vascular diseases. Participants will have full-body images taken from the front and back during their primary care visit. Some participants may also have manual body measurements taken as part of routine care. Those interested may have repeated image and measurement sessions yearly. Participants will fill out a questionnaire about their medical history related to the studied conditions during the visit. Researchers will evaluate the sensitivity of the imaging for detecting lesions needing removal, dermatological conditions, and changes in lesions compared to visual inspection and traditional measurements. Thermal gradients will be analyzed for correlations with peripheral arterial disease and Raynaud's phenomenon. Follow-up assessments may occur at one year. The study offers a non-invasive way to collect detailed skin and body data with ongoing safety and diagnostic monitoring.

Multi-modal Quantitative Imaging of the Skin